These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 5135686)

  • 1. [Clinical and pharmacodynamic correlations of phenobarbital (PB) and diphenylhydantoin (DPH) in the treatment of infantile epilepsy].
    De Negri M; Luciano L
    Minerva Pediatr; 1971 Dec; 23(50):2103-12. PubMed ID: 5135686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
    Morselli PL; Rizzo M; Garattini S
    Ann N Y Acad Sci; 1971 Jul; 179():88-107. PubMed ID: 5285399
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of phenobarbital and diphenylhydantoin on some blood cation transport systems in epileptics.
    Mison-Crighel N; Pintilie C; Florescu D; Tudor S; Volanschi D
    Rev Roum Neurol; 1973; 10(5):451-9. PubMed ID: 4758239
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships among dose, serum and CSF levels and urinary output in fenobarbital and fenitoin treatment of epileptics.
    Pintilie C; Florescu D; Tudor S; Alecu C; Macovei-Patriche M; Volanschi D
    Neurol Psychiatr (Bucur); 1975; 13(2):101-10. PubMed ID: 1188268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spindles and spike waves in the sleep EEG of epileptic patients under administration of phenobarbital (PB) and phenytoin (DPH) (author's transl)].
    Sengoku A; Wolf P
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1981 Sep; 12(3):132-4. PubMed ID: 6795018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epilepsy in children].
    Kortbeek LH
    Ned Tijdschr Geneeskd; 1974 Aug; 118(31):1186-94. PubMed ID: 4210838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in the treatment of a patient with longstanding epilepsy (author's transl)].
    Missoum A; Riche C; Guedes Y; Goas JY
    Sem Hop; 1981 Nov 18-25; 57(43-44):1869-72. PubMed ID: 6274040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the mechanism of metabolic acidosis observed in the children treated with anticonvulsants].
    Nagai B
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):706-21. PubMed ID: 6820790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the serum levels of phenobarbital and diphenylhydantoin and clinical data in patients with drug resistant epilepsy.
    Bendarzewska-Nawrocka B; Pietruszewska E; Bacia T
    Monogr Neural Sci; 1980; 5():229-34. PubMed ID: 7322157
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of anticonvulsant levels in human plasma and epileptogenic brain.
    Sherwin AL; Eisen AA; Sokolowski CD
    Trans Am Neurol Assoc; 1973; 98():199-203. PubMed ID: 4784934
    [No Abstract]   [Full Text] [Related]  

  • 17. Are phenobarbital and phenytoin obsolete in the treatment of epilepsy?
    Gourie-Devi M; Stevens J; Osuntokun BO; Levy LF
    J Assoc Physicians India; 1988 Jul; 36(7):458. PubMed ID: 3204096
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. A study of the clinical effects.
    Volanschi D; Pintilie C
    Neurol Psychiatr (Bucur); 1978; 16(4):259-69. PubMed ID: 741196
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 20. Neonatal effects of maternal treatment with the anticonvulsant drug diphenylhydantoin.
    Watson JD; Spellacy WN
    Obstet Gynecol; 1971 Jun; 37(6):881-5. PubMed ID: 4378213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.